Condition: Interstitial Lung Disease · Chronic Thromboembolic Pulmonary Hypertension · Acute Pulmonary Embolism · Sponsor: Bastiaan Driehuys
The goal of this NIH-sponsored study is to characterize three biomarkers derived from 129Xe gas exchange MRI and to understand how they change in response to interventions.
This description comes directly from the study's public registry record.
Bastiaan Driehuys, PhD · 919-684-7786 · bastiaan.driehuys@duke.edu
Always discuss trial participation with your own doctor first.
| Duke University Medical Center | Durham, North Carolina, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06038630